asa guidelines for glp 1 agonists Perioperative anesthesia management of GLP-1 receptor agonists: a systematic review of potential risks | Perioperative Medicine Evolving Role of Double and
Description
Their repurposing aligns with precision medicine paradigms, enabling tailored therapies for patients with comorbid conditions like obesity, diabetes, and chronic pain

Observational studies further reveal reductions in alcohol, opioid, and cannabis use in real-world populations treated with GLP-1RAs, reinforcing the clinical relevance of GBA signaling in addiction
On the cost front, while insurance coverage for GLP1 receptor agonists has increased as of late, many payers still do not cover these medications for obesity alone (i.e., without the presence of other approved indications)

Call to Action Curious about whether GLP-1 therapies or future medications like retatrutide are right for you

Sources American Diabetes Association

Fatigue: This can be a frustrating side effect, especially if you are an always-on-the-go type of personor if your busy schedule has made you into one
